IL1R2 constitutes a decoy interleukin receptor, that abrogates interleukin-1 signaling and is known for strong expression in serum and tumor tissue in EBV-related Hodgkin lymphoma [41]. The gene discussed is IL1R2; the disease is neoplasm.